Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body for therapeutic effect.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Partnering Terms and Agreements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Partnering Terms and Agreements. This report contains market size and forecasts of Drug Delivery Partnering Terms and Agreements in global, including the following market information:
Global Drug Delivery Partnering Terms and Agreements Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drug Delivery Partnering Terms and Agreements market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pumps Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drug Delivery Partnering Terms and Agreements include 3DMed Corporation, AIT Therapeutics, Apellis Pharmaceuticals, Avanos Medical, Biosensors International(Bluesail Medical), CarpalAid, Acerus Pharmaceuticals, Colorcon and Clear Guide Medical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Delivery Partnering Terms and Agreements companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Delivery Partnering Terms and Agreements Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drug Delivery Partnering Terms and Agreements Market Segment Percentages, by Type, 2022 (%)
Pumps
Syringes
Inhalers
Others
Global Drug Delivery Partnering Terms and Agreements Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drug Delivery Partnering Terms and Agreements Market Segment Percentages, by Application, 2022 (%)
Patient
Hospitals and Clinics
Research Institute
Others
Global Drug Delivery Partnering Terms and Agreements Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drug Delivery Partnering Terms and Agreements Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Delivery Partnering Terms and Agreements revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drug Delivery Partnering Terms and Agreements revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3DMed Corporation
AIT Therapeutics
Apellis Pharmaceuticals
Avanos Medical
Biosensors International(Bluesail Medical)
CarpalAid
Acerus Pharmaceuticals
Colorcon
Clear Guide Medical
Chiome Bioscience, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Delivery Partnering Terms and Agreements, market overview.
Chapter 2: Global Drug Delivery Partnering Terms and Agreements market size in revenue.
Chapter 3: Detailed analysis of Drug Delivery Partnering Terms and Agreements company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Delivery Partnering Terms and Agreements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drug Delivery Partnering Terms and Agreements Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Delivery Partnering Terms and Agreements Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Delivery Partnering Terms and Agreements Overall Market Size
2.1 Global Drug Delivery Partnering Terms and Agreements Market Size: 2022 VS 2029
2.2 Global Drug Delivery Partnering Terms and Agreements Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Delivery Partnering Terms and Agreements Players in Global Market
3.2 Top Global Drug Delivery Partnering Terms and Agreements Companies Ranked by Revenue
3.3 Global Drug Delivery Partnering Terms and Agreements Revenue by Companies
3.4 Top 3 and Top 5 Drug Delivery Partnering Terms and Agreements Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drug Delivery Partnering Terms and Agreements Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Delivery Partnering Terms and Agreements Players in Global Market
3.6.1 List of Global Tier 1 Drug Delivery Partnering Terms and Agreements Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Delivery Partnering Terms and Agreements Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drug Delivery Partnering Terms and Agreements Market Size Markets, 2022 & 2029
4.1.2 Pumps
4.1.3 Syringes
4.1.4 Inhalers
4.1.5 Others
4.2 By Type - Global Drug Delivery Partnering Terms and Agreements Revenue & Forecasts
4.2.1 By Type - Global Drug Delivery Partnering Terms and Agreements Revenue, 2018-2023
4.2.2 By Type - Global Drug Delivery Partnering Terms and Agreements Revenue, 2024-2029
4.2.3 By Type - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Delivery Partnering Terms and Agreements Market Size, 2022 & 2029
5.1.2 Patient
5.1.3 Hospitals and Clinics
5.1.4 Research Institute
5.1.5 Others
5.2 By Application - Global Drug Delivery Partnering Terms and Agreements Revenue & Forecasts
5.2.1 By Application - Global Drug Delivery Partnering Terms and Agreements Revenue, 2018-2023
5.2.2 By Application - Global Drug Delivery Partnering Terms and Agreements Revenue, 2024-2029
5.2.3 By Application - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drug Delivery Partnering Terms and Agreements Market Size, 2022 & 2029
6.2 By Region - Global Drug Delivery Partnering Terms and Agreements Revenue & Forecasts
6.2.1 By Region - Global Drug Delivery Partnering Terms and Agreements Revenue, 2018-2023
6.2.2 By Region - Global Drug Delivery Partnering Terms and Agreements Revenue, 2024-2029
6.2.3 By Region - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drug Delivery Partnering Terms and Agreements Revenue, 2018-2029
6.3.2 US Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.3.3 Canada Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.3.4 Mexico Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drug Delivery Partnering Terms and Agreements Revenue, 2018-2029
6.4.2 Germany Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4.3 France Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4.4 U.K. Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4.5 Italy Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4.6 Russia Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4.7 Nordic Countries Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.4.8 Benelux Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drug Delivery Partnering Terms and Agreements Revenue, 2018-2029
6.5.2 China Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.5.3 Japan Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.5.4 South Korea Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.5.5 Southeast Asia Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.5.6 India Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drug Delivery Partnering Terms and Agreements Revenue, 2018-2029
6.6.2 Brazil Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.6.3 Argentina Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Delivery Partnering Terms and Agreements Revenue, 2018-2029
6.7.2 Turkey Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.7.3 Israel Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.7.4 Saudi Arabia Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
6.7.5 UAE Drug Delivery Partnering Terms and Agreements Market Size, 2018-2029
7 Drug Delivery Partnering Terms and Agreements Companies Profiles
7.1 3DMed Corporation
7.1.1 3DMed Corporation Company Summary
7.1.2 3DMed Corporation Business Overview
7.1.3 3DMed Corporation Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.1.4 3DMed Corporation Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.1.5 3DMed Corporation Key News & Latest Developments
7.2 AIT Therapeutics
7.2.1 AIT Therapeutics Company Summary
7.2.2 AIT Therapeutics Business Overview
7.2.3 AIT Therapeutics Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.2.4 AIT Therapeutics Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.2.5 AIT Therapeutics Key News & Latest Developments
7.3 Apellis Pharmaceuticals
7.3.1 Apellis Pharmaceuticals Company Summary
7.3.2 Apellis Pharmaceuticals Business Overview
7.3.3 Apellis Pharmaceuticals Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.3.4 Apellis Pharmaceuticals Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.3.5 Apellis Pharmaceuticals Key News & Latest Developments
7.4 Avanos Medical
7.4.1 Avanos Medical Company Summary
7.4.2 Avanos Medical Business Overview
7.4.3 Avanos Medical Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.4.4 Avanos Medical Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.4.5 Avanos Medical Key News & Latest Developments
7.5 Biosensors International(Bluesail Medical)
7.5.1 Biosensors International(Bluesail Medical) Company Summary
7.5.2 Biosensors International(Bluesail Medical) Business Overview
7.5.3 Biosensors International(Bluesail Medical) Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.5.4 Biosensors International(Bluesail Medical) Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.5.5 Biosensors International(Bluesail Medical) Key News & Latest Developments
7.6 CarpalAid
7.6.1 CarpalAid Company Summary
7.6.2 CarpalAid Business Overview
7.6.3 CarpalAid Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.6.4 CarpalAid Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.6.5 CarpalAid Key News & Latest Developments
7.7 Acerus Pharmaceuticals
7.7.1 Acerus Pharmaceuticals Company Summary
7.7.2 Acerus Pharmaceuticals Business Overview
7.7.3 Acerus Pharmaceuticals Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.7.4 Acerus Pharmaceuticals Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.7.5 Acerus Pharmaceuticals Key News & Latest Developments
7.8 Colorcon
7.8.1 Colorcon Company Summary
7.8.2 Colorcon Business Overview
7.8.3 Colorcon Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.8.4 Colorcon Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.8.5 Colorcon Key News & Latest Developments
7.9 Clear Guide Medical
7.9.1 Clear Guide Medical Company Summary
7.9.2 Clear Guide Medical Business Overview
7.9.3 Clear Guide Medical Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.9.4 Clear Guide Medical Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.9.5 Clear Guide Medical Key News & Latest Developments
7.10 Chiome Bioscience, Inc
7.10.1 Chiome Bioscience, Inc Company Summary
7.10.2 Chiome Bioscience, Inc Business Overview
7.10.3 Chiome Bioscience, Inc Drug Delivery Partnering Terms and Agreements Major Product Offerings
7.10.4 Chiome Bioscience, Inc Drug Delivery Partnering Terms and Agreements Revenue in Global Market (2018-2023)
7.10.5 Chiome Bioscience, Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drug Delivery Partnering Terms and Agreements Market Opportunities & Trends in Global Market
Table 2. Drug Delivery Partnering Terms and Agreements Market Drivers in Global Market
Table 3. Drug Delivery Partnering Terms and Agreements Market Restraints in Global Market
Table 4. Key Players of Drug Delivery Partnering Terms and Agreements in Global Market
Table 5. Top Drug Delivery Partnering Terms and Agreements Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drug Delivery Partnering Terms and Agreements Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drug Delivery Partnering Terms and Agreements Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drug Delivery Partnering Terms and Agreements Product Type
Table 9. List of Global Tier 1 Drug Delivery Partnering Terms and Agreements Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Delivery Partnering Terms and Agreements Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drug Delivery Partnering Terms and Agreements Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drug Delivery Partnering Terms and Agreements Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drug Delivery Partnering Terms and Agreements Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drug Delivery Partnering Terms and Agreements Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2024-2029
Table 30. 3DMed Corporation Company Summary
Table 31. 3DMed Corporation Drug Delivery Partnering Terms and Agreements Product Offerings
Table 32. 3DMed Corporation Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 33. 3DMed Corporation Key News & Latest Developments
Table 34. AIT Therapeutics Company Summary
Table 35. AIT Therapeutics Drug Delivery Partnering Terms and Agreements Product Offerings
Table 36. AIT Therapeutics Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 37. AIT Therapeutics Key News & Latest Developments
Table 38. Apellis Pharmaceuticals Company Summary
Table 39. Apellis Pharmaceuticals Drug Delivery Partnering Terms and Agreements Product Offerings
Table 40. Apellis Pharmaceuticals Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 41. Apellis Pharmaceuticals Key News & Latest Developments
Table 42. Avanos Medical Company Summary
Table 43. Avanos Medical Drug Delivery Partnering Terms and Agreements Product Offerings
Table 44. Avanos Medical Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 45. Avanos Medical Key News & Latest Developments
Table 46. Biosensors International(Bluesail Medical) Company Summary
Table 47. Biosensors International(Bluesail Medical) Drug Delivery Partnering Terms and Agreements Product Offerings
Table 48. Biosensors International(Bluesail Medical) Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 49. Biosensors International(Bluesail Medical) Key News & Latest Developments
Table 50. CarpalAid Company Summary
Table 51. CarpalAid Drug Delivery Partnering Terms and Agreements Product Offerings
Table 52. CarpalAid Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 53. CarpalAid Key News & Latest Developments
Table 54. Acerus Pharmaceuticals Company Summary
Table 55. Acerus Pharmaceuticals Drug Delivery Partnering Terms and Agreements Product Offerings
Table 56. Acerus Pharmaceuticals Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 57. Acerus Pharmaceuticals Key News & Latest Developments
Table 58. Colorcon Company Summary
Table 59. Colorcon Drug Delivery Partnering Terms and Agreements Product Offerings
Table 60. Colorcon Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 61. Colorcon Key News & Latest Developments
Table 62. Clear Guide Medical Company Summary
Table 63. Clear Guide Medical Drug Delivery Partnering Terms and Agreements Product Offerings
Table 64. Clear Guide Medical Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 65. Clear Guide Medical Key News & Latest Developments
Table 66. Chiome Bioscience, Inc Company Summary
Table 67. Chiome Bioscience, Inc Drug Delivery Partnering Terms and Agreements Product Offerings
Table 68. Chiome Bioscience, Inc Drug Delivery Partnering Terms and Agreements Revenue (US$, Mn) & (2018-2023)
Table 69. Chiome Bioscience, Inc Key News & Latest Developments
List of Figures
Figure 1. Drug Delivery Partnering Terms and Agreements Segment by Type in 2022
Figure 2. Drug Delivery Partnering Terms and Agreements Segment by Application in 2022
Figure 3. Global Drug Delivery Partnering Terms and Agreements Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drug Delivery Partnering Terms and Agreements Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drug Delivery Partnering Terms and Agreements Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Delivery Partnering Terms and Agreements Revenue in 2022
Figure 8. By Type - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 16. US Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 20. Germany Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 21. France Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 28. China Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 32. India Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 34. Brazil Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drug Delivery Partnering Terms and Agreements Revenue Market Share, 2018-2029
Figure 37. Turkey Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drug Delivery Partnering Terms and Agreements Revenue, (US$, Mn), 2018-2029
Figure 41. 3DMed Corporation Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AIT Therapeutics Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Apellis Pharmaceuticals Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Avanos Medical Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Biosensors International(Bluesail Medical) Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CarpalAid Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Acerus Pharmaceuticals Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Colorcon Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Clear Guide Medical Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Chiome Bioscience, Inc Drug Delivery Partnering Terms and Agreements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
